The Food and Drug Administration upgraded the recall of a type of commonly used thyroid medication due to low potency issues, according to a notice posted by the agency.
The agency said that 54,432 bottles of levothyroxine sodium tablets are being recalled because of sub-potency and upgraded the recall to Class II on Oct. 6. The prescription-only tablets come in 88 mcg, or 0.088 milligram, amounts at 90 tablets per bottle, the notice said.
They were distributed by Accord Healthcare Inc. of Raleigh, North Carolina, and manufactured by Intas Pharmaceuticals Ltd., based in India, according to the FDA. The firm voluntarily initiated the recall, the agency said….